Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
10-Dec-2025 | 330.1 | 334 | 307.75 | 310.8 | 19,282 | 31,37,98,126.15 | 3,24,955 |
11-Dec-2025 | 312.8 | 322 | 306.4 | 320.9 | 11,411 | 16,01,03,535.55 | 1,25,719 |
12-Dec-2025 | 320.9 | 322.95 | 314.5 | 320.7 | 6,165 | 8,00,09,771.8 | 93,445 |
15-Dec-2025 | 325 | 328 | 320.7 | 323.95 | 9,394 | 14,87,30,383.15 | 1,43,243 |
16-Dec-2025 | 325.4 | 325.4 | 315 | 316.15 | 4,308 | 7,06,04,555.3 | 98,698 |
17-Dec-2025 | 317 | 317.7 | 304.2 | 310.05 | 5,863 | 8,56,16,200.95 | 80,327 |
18-Dec-2025 | 310.1 | 310.8 | 302.1 | 303.75 | 4,649 | 6,47,35,317.35 | 81,689 |
19-Dec-2025 | 304.8 | 314 | 304.15 | 311.3 | 5,994 | 7,49,78,479.65 | 65,693 |
22-Dec-2025 | 311.75 | 316.55 | 311.75 | 313.7 | 3,217 | 3,94,53,588.1 | 47,814 |
23-Dec-2025 | 316 | 316.65 | 310.05 | 315.25 | 4,440 | 5,14,00,717.95 | 70,317 |
24-Dec-2025 | 313.7 | 320.75 | 311 | 311.7 | 3,996 | 5,46,86,421.6 | 69,838 |
26-Dec-2025 | 312.8 | 313.55 | 305 | 306.25 | 3,719 | 5,07,63,290.45 | 71,900 |
29-Dec-2025 | 306.25 | 315 | 302.05 | 310 | 4,467 | 5,03,09,047.95 | 63,513 |
30-Dec-2025 | 313.1 | 315.65 | 307.1 | 313.9 | 4,990 | 4,60,95,759.4 | 51,242 |
31-Dec-2025 | 310.75 | 314.55 | 306.25 | 310.4 | 4,172 | 4,11,94,433.35 | 60,929 |
01-Jan-2026 | 309.4 | 316.55 | 308.4 | 313.45 | 3,503 | 3,55,80,580.2 | 49,100 |
02-Jan-2026 | 313.45 | 330.7 | 311 | 326.25 | 7,914 | 13,83,82,578.7 | 2,52,717 |
05-Jan-2026 | 331.15 | 341.9 | 326.35 | 335.7 | 21,435 | 37,23,98,722.4 | 3,32,931 |
06-Jan-2026 | 337.95 | 347.9 | 326.5 | 343.05 | 15,435 | 21,21,83,351.3 | 2,21,259 |
07-Jan-2026 | 341.35 | 349 | 337.15 | 345 | 12,380 | 14,34,52,941.55 | 1,18,887 |
08-Jan-2026 | 340.3 | 360 | 338 | 343.4 | 25,300 | 31,13,64,616.65 | 2,43,778 |
09-Jan-2026 | 338 | 345.95 | 333.8 | 338.95 | 10,745 | 15,31,82,354.9 | 1,58,966 |
SMS Pharma added that it will submit its formal response to the USFDA within the stipulated timeline, in line with standard regulatory practice.
For the June quarter, SMS Pharma reported a 24.3% year-on-year jump in net profit to ₹20.49 crore, compared with ₹16.48 crore a year earlier.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
